Follow the people · Insider
Anthony James Culverwell
Anthony James Culverwell files insider transactions with the SEC as a director of Quoin Pharmaceuticals (QNRX). We hold 1 disclosed purchase or sale filed since 26 July 2017, 1 of them in the last 90 days.
- Files forQNRX
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure1 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 26 October 2023 — 31 August 2026Director · Quoin Pharmaceuticals (QNRX)12 Form 4 lines · source: SEC Form 4
- Filed 24 July 2017 — 24 July 2017Director · Innocoll Holdings (INNL)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
17 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 6,146 shares of Quoin PharmaceuticalsSEC Form 41 September 2026ADSs · traded 31 August 2026 · filed 1 September 2026
- ▲ bought on the open market 3,073 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 41 September 2026Ordinary Warrants (Right to Buy) · traded 31 August 2026 · filed 1 September 2026
- was granted 31,352 shares of Quoin PharmaceuticalsSEC Form 428 August 2026ADSs · traded 27 August 2026 · filed 28 August 2026
- was granted 21,709 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 46 February 2026Share Option (Right to Buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 21,709 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 46 February 2026Share Option (Right to Buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 13,682 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 425 August 2025Share Option (Right to Buy) · traded 21 August 2025 · filed 25 August 2025
- was granted 7,760 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 43 June 2025Share Option (Right to Buy) · traded 29 May 2025 · filed 3 June 2025
- ▲ bought on the open market 100,000 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 427 December 2024Series F Warrants (right to buy) · traded 23 December 2024 · filed 27 December 2024
- ▲ bought on the open market 100,000 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 427 December 2024Series G Warrants (right to buy) · traded 23 December 2024 · filed 27 December 2024
- ▲ bought on the open market 100,000 shares of Quoin PharmaceuticalsSEC Form 427 December 2024Ordinary Shares · traded 23 December 2024 · filed 27 December 2024
- was granted 50,714 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 410 December 2024Share Option (Right to Buy) · traded 9 December 2024 · filed 10 December 2024
- was granted 7,652 shares of Quoin Pharmaceuticals (a derivative holding)SEC Form 430 October 2023Share Option (Right to Buy) · traded 26 October 2023 · filed 30 October 2023
- returned to the issuer 291,566 shares of Innocoll HoldingsSEC Form 426 July 2017Ordinary Shares, par value $0.01 per share · traded 24 July 2017 · filed 26 July 2017
- returned to the issuer 11,659 shares of Innocoll Holdings (a derivative holding)SEC Form 426 July 2017Stock Option (right to buy) · traded 24 July 2017 · filed 26 July 2017
- returned to the issuer 8,230 shares of Innocoll Holdings (a derivative holding)SEC Form 426 July 2017Stock Option (right to buy) · traded 24 July 2017 · filed 26 July 2017
- returned to the issuer 14,907 shares of Innocoll Holdings (a derivative holding)SEC Form 426 July 2017Stock Option (right to buy) · traded 24 July 2017 · filed 26 July 2017
- returned to the issuer 57,240 shares of Innocoll Holdings (a derivative holding)SEC Form 426 July 2017Warrant · traded 24 July 2017 · filed 26 July 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.